Sinici Lay Incilay, Pınar Aslı, Akbıyık Filiz
Hacettepe University Faculty of Medicine, Department of Medical Biochemistry, Turkey; Hacettepe University Hospitals, Clinical Pathology Laboratory, Ankara, Turkey.
Hacettepe University Faculty of Medicine, Department of Medical Biochemistry, Turkey; Hacettepe University Hospitals, Clinical Pathology Laboratory, Ankara, Turkey.
Clin Biochem. 2014 Aug;47(12):1002-5. doi: 10.1016/j.clinbiochem.2014.04.024. Epub 2014 May 2.
Specific types of error should be identified and corrected in each laboratory to ensure quality results. The objectives of this study were:
Data on rejected biological specimens in the laboratory information system from January 2013 to January 2014 were analyzed. SSRs according to the type of pre-preanalytical error and collection area were determined.
In total, 971,780 biological specimens were received during the period and 26,070 (2.7%) specimens were rejected based on our laboratory rejection criteria. The most frequent reason for the rejection was the clotted specimen (55.8% of total rejections), followed by inadequate volume (29.3% of total rejections). Most of the clotted specimens were received from adult hospital inpatient services (54.3%), followed by pediatric hospital inpatient services (26.8%). High rates of inadequate volume were also observed in samples originating from adult and pediatric hospital inpatient services, especially in the premature, neonatal, intensive care, and oncology units.
The SSR of clotted specimens was selected as the QI for the preanalytical phase in our laboratory. The selected QI will help to define the effects of our specific interventions and corrective actions, and thus allow monitoring of quality improvement in our hospitals.
每个实验室都应识别并纠正特定类型的误差,以确保获得高质量结果。本研究的目的如下:
对2013年1月至2014年1月实验室信息系统中被拒收的生物标本数据进行分析。根据分析前误差类型和采集区域确定标本拒收率(SSRs)。
在此期间共接收971,780份生物标本,根据我们实验室的拒收标准,有26,070份(2.7%)标本被拒收。最常见的拒收原因是标本凝血(占总拒收标本的55.8%),其次是标本量不足(占总拒收标本的29.3%)。大多数凝血标本来自成人医院住院部(54.3%),其次是儿科医院住院部(26.8%)。在来自成人和儿科医院住院部的标本中也观察到高比例的标本量不足情况,尤其是在早产儿、新生儿、重症监护和肿瘤科。
凝血标本的标本拒收率被选为我们实验室分析前阶段的质量指标(QI)。所选的质量指标将有助于确定我们特定干预措施和纠正行动的效果,从而能够监测我们医院的质量改进情况。